Moleculent
Agent47Agent Readiness: 47/100. Above median. Measured by StartupHub.ai. Median 41.Trust82Data Trust: 82/100. Top 25%. Measured by StartupHub.ai. Median 61.Mapping cell-cell communication at scale in human tissue.
About
Moleculent is a life sciences technology company focused on decoding the molecular foundation of biology by mapping cell-cell communication within human tissue. Their platform provides a functional layer of understanding to uncover new insights into cellular biology, health, and disease, with applications in areas like immunotherapy and understanding drug response. They serve researchers and scientists seeking to advance life science breakthroughs.
Listed competitors
Moleculent focuses on mapping cell-cell communication directly in tissue, providing a functional layer of understanding, while Matterworks may have a different approach to biological analysis.
Moleculent's core technology is mapping cell-cell communication, whereas Enterome focuses on the microbiome and its role in health and disease.
Moleculent's platform is designed for high-plex functional profiling of cell-cell interactions, while Leman Biotech may focus on different aspects of biotechnology or drug development.
Also in this space
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, HealthTech
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, HealthTech
AI-powered platform for understanding disease biology and accelerating drug discovery.
Shares Biotech, Drug Discovery
AI-guided drug discovery platform for tissue-targeted medicines.
Shares Biotech, Drug Discovery
Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
Shares Biotech, HealthTech
Key facts
- Website
- moleculent.com
- Headquarters
- Stockholm, Sweden
- Founded
- 2019
- Employees
- 64
- Total funding
- $46M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 30 Apr 2026 | Series B | $20M | |
| 11 Jun 2024 | Series A | $26M | Arch Venture Partners |
Tech stack
Detected on moleculent.com, last scanned 18 Oct 2026. Run your own scan
- Frontend
- Tailwind CSS
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- Support
- HubSpot
- CMS / Builders
- WordPress
- Hosting
- AWS
- Email provider
- Microsoft 365
Moleculent scores 36. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Moleculent trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Moleculent is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Moleculent raised?
Moleculent has raised a total of $46M in funding. The most recent round on record is Series B.
How many employees does Moleculent have?
Moleculent has approximately 64 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Moleculent
